Richmond Pharmacology is glad to be attending the ACCP Annual Meeting 2025, hosted by the American College of Clinical Pharmacology, in Phoenix, Arizona, from 14th –16th September.
Representing Richmond at the ACCP Annual Meeting:
Dr Jörg Täubel, Chief Executive Officer
James Rickard, Chief Scientific Officer
Richmond looks forward to discussing our expertise in:
• Translational and early-phase clinical pharmacology
• First-in-human and adaptive trial designs
• Innovative dose escalation and safety assessment
• Pharmacokinetic/pharmacodynamic modelling
• Regulatory collaboration and strategic guidance
If you’re attending ACCP 2025 and seeking a partner in clinical pharmacology and drug development, get in touch with us today to arrange a meeting: info@richmondpharmacology.com
.svg){kind=small}
-min.jpg)
.jpg)
